HopeStage
Back to all studies
RecruitingNCT05900271

Five-day accelerated iTBS compared with six-week rTMS for treatment-resistant depression

About this titleRead the official source — NCT05900271
Device studyAges 18–99Netherlands
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 99 years. Other eligibility criteria apply.

What will I do during this study?

Participants are assigned to either a five-day accelerated course of multiple daily theta-burst stimulation sessions or a standard course of 10 Hz rTMS delivered over six weeks.

Listed locations
Nijmegen and 3 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 15, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
108
Sponsor
Amsterdam UMC, location VUmc
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Netherlands
Age range
From 18 Years to 99 Years
Official registry ID
NCT05900271
Official title
Show the full official title

Higher, Faster, Better: Is an Accelerated Intermittent Theta Burst Stimulation Protocol Compared to Standard 10 Hz Repetitive Transcranial Magnetic Stimulation, More (Cost-) Effective in Patients With Treatment-resistant Depression?

Recruitment & locations

Currently recruiting

Nijmegen · Amsterdam · Amsterdam-Zuidoost

1 more locations
  • Maastricht

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Amsterdam UMC, location VUmc.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 99 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies